Wedbush initiated coverage of Sana Biotechnology (SANA) with an Outperform rating and $5 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Sana Biotechnology Announces Leadership Transition
- Sana Biotechnology Board Member Resigns Effective August 29
- Sana Biotechnology Reports Q2 2025 Financial Results
- Sana Biotechnology’s Strategic Advances and Positive FDA Feedback Bolster Buy Rating
- Sana Biotechnology’s Promising Advances in Diabetes Treatment and Strong Financial Position Support Buy Rating